{"entity":{"type":"insider","cik":"0001599324","url":"/insider/0001599324","json_url":"/insider/0001599324.json","name":"Christensen Jamie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":43,"n_filings":29,"first":"2015-02-19","last":"2024-01-18","span_basis":"filed_date"},"name_variants":[{"name":"Christensen Jamie","source":"filing","n_filings":29,"first_seen":"2015-02-19","last_seen":"2024-01-18"}],"transactions":[{"id":2921483,"accession":"0001628280-24-001690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-001690","line_url":"/filing/0001628280-24-001690","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1597.0,"shares_display":"1,597","price_per_share":59.02,"price_display":"59.02","price_state":"stated","total_value":94254.94,"total_display":"94,254.94","total_whole":"94,255","shares_owned_after":156558.0,"shares_owned_after_display":"156,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider","n_lines":2},{"id":2611700,"accession":"0001628280-24-000699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-000699","line_url":"/filing/0001628280-24-000699#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1531.0,"shares_display":"1,531","price_per_share":58.81,"price_display":"58.81","price_state":"stated","total_value":90038.11,"total_display":"90,038.11","total_whole":"90,038","shares_owned_after":157135.0,"shares_owned_after_display":"157,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":8340365,"accession":"0001628280-23-042001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-042001","line_url":"/filing/0001628280-23-042001#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2387.0,"shares_display":"2,387","price_per_share":57.5,"price_display":"57.50","price_state":"stated","total_value":137252.5,"total_display":"137,252.50","total_whole":"137,253","shares_owned_after":141645.0,"shares_owned_after_display":"141,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-19","scope":"insider"},{"id":8025439,"accession":"0001628280-23-032116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-032116","line_url":"/filing/0001628280-23-032116#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2388.0,"shares_display":"2,388","price_per_share":35.63,"price_display":"35.63","price_state":"stated","total_value":85084.44,"total_display":"85,084.44","total_whole":"85,084","shares_owned_after":144032.0,"shares_owned_after_display":"144,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-08","filed_date":"2023-09-12","scope":"insider"},{"id":8510298,"accession":"0001628280-23-019629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-019629","line_url":"/filing/0001628280-23-019629#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":619.0,"shares_display":"619","price_per_share":45.2905,"price_display":"45.29","price_state":"stated","total_value":28034.8195,"total_display":"28,034.82","total_whole":"28,035","shares_owned_after":124123.0,"shares_owned_after_display":"124,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-24","filed_date":"2023-05-24","scope":"insider"},{"id":8442281,"accession":"0001214659-23-000809","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-23-000809","line_url":"/filing/0001214659-23-000809","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2245.0,"shares_display":"2,245","price_per_share":42.37949893095768,"price_display":"42.38","price_state":"stated","total_value":95141.9751,"total_display":"95,141.98","total_whole":"95,142","shares_owned_after":98765.0,"shares_owned_after_display":"98,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider","n_lines":2},{"id":8341314,"accession":"0001214659-23-000289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-23-000289","line_url":"/filing/0001214659-23-000289#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1949.0,"shares_display":"1,949","price_per_share":46.6,"price_display":"46.60","price_state":"stated","total_value":90823.4,"total_display":"90,823.40","total_whole":"90,823","shares_owned_after":100123.0,"shares_owned_after_display":"100,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":6128647,"accession":"0001214659-22-015125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-015125","line_url":"/filing/0001214659-22-015125#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2410.0,"shares_display":"2,410","price_per_share":42.9977,"price_display":"43.00","price_state":"stated","total_value":103624.457,"total_display":"103,624.46","total_whole":"103,624","shares_owned_after":102072.0,"shares_owned_after_display":"102,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-20","scope":"insider"},{"id":6736624,"accession":"0001214659-22-014531","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-014531","line_url":"/filing/0001214659-22-014531#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1726.0,"shares_display":"1,726","price_per_share":90.1893,"price_display":"90.19","price_state":"stated","total_value":155666.7318,"total_display":"155,666.73","total_whole":"155,667","shares_owned_after":104482.0,"shares_owned_after_display":"104,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-05","scope":"insider"},{"id":6663914,"accession":"0001214659-22-008031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-008031","line_url":"/filing/0001214659-22-008031#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":624.0,"shares_display":"624","price_per_share":63.54,"price_display":"63.54","price_state":"stated","total_value":39648.96,"total_display":"39,648.96","total_whole":"39,649","shares_owned_after":86804.0,"shares_owned_after_display":"86,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-06-14","scope":"insider"},{"id":6375729,"accession":"0001214659-22-000857","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-22-000857","line_url":"/filing/0001214659-22-000857#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":627.0,"shares_display":"627","price_per_share":120.5067,"price_display":"120.51","price_state":"stated","total_value":75557.7009,"total_display":"75,557.70","total_whole":"75,558","shares_owned_after":87428.0,"shares_owned_after_display":"87,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-18","scope":"insider"},{"id":6361359,"accession":"0001214659-22-000418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-000418","line_url":"/filing/0001214659-22-000418#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1442.0,"shares_display":"1,442","price_per_share":147.7235,"price_display":"147.72","price_state":"stated","total_value":213017.287,"total_display":"213,017.29","total_whole":"213,017","shares_owned_after":77300.0,"shares_owned_after_display":"77,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-06","scope":"insider"},{"id":5539403,"accession":"0001214659-21-012820","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-21-012820","line_url":"/filing/0001214659-21-012820","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1201.0,"shares_display":"1,201","price_per_share":130.78914238134888,"price_display":"130.79","price_state":"stated","total_value":157077.76,"total_display":"157,077.76","total_whole":"157,078","shares_owned_after":59514.0,"shares_owned_after_display":"59,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider","n_lines":2},{"id":5508168,"accession":"0001214659-21-005911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-21-005911","line_url":"/filing/0001214659-21-005911#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":435.0,"shares_display":"435","price_per_share":154.34,"price_display":"154.34","price_state":"stated","total_value":67137.9,"total_display":"67,137.90","total_whole":"67,138","shares_owned_after":53850.0,"shares_owned_after_display":"53,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-25","scope":"insider"},{"id":5210099,"accession":"0001214659-21-000335","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-000335","line_url":"/filing/0001214659-21-000335","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1459.0,"shares_display":"1,459","price_per_share":210.3911918437286,"price_display":"210.39","price_state":"stated","total_value":306960.7489,"total_display":"306,960.75","total_whole":"306,961","shares_owned_after":47262.0,"shares_owned_after_display":"47,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-08","scope":"insider","n_lines":2},{"id":8301513,"accession":"0001214659-19-008005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-19-008005","line_url":"/filing/0001214659-19-008005","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6666.0,"shares_display":"6,666","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":833250.0,"total_display":"833,250.00","total_whole":"833,250","shares_owned_after":9159.0,"shares_owned_after_display":"9,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-23","filed_date":"2019-12-26","scope":"insider","n_lines":2},{"id":6398510,"accession":"0001214659-18-004614","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001214659-18-004614","line_url":"/filing/0001214659-18-004614","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4999.0,"shares_display":"4,999","price_per_share":49.542918223644726,"price_display":"49.54","price_state":"stated","total_value":247665.0482,"total_display":"247,665.05","total_whole":"247,665","shares_owned_after":4159.0,"shares_owned_after_display":"4,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2018-06-28","scope":"insider","n_lines":3},{"id":6398498,"accession":"0001214659-18-004614","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-18-004614","line_url":"/filing/0001214659-18-004614","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5208.0,"shares_display":"5,208","price_per_share":48.76435760368663,"price_display":"48.76","price_state":"stated","total_value":253964.7744,"total_display":"253,964.77","total_whole":"253,965","shares_owned_after":4027.0,"shares_owned_after_display":"4,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-26","filed_date":"2018-06-28","scope":"insider","n_lines":2},{"id":6427770,"accession":"0001214659-18-003059","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-18-003059","line_url":"/filing/0001214659-18-003059#line-4","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22000.0,"shares_display":"22,000","price_per_share":33.0018,"price_display":"33.00","price_state":"stated","total_value":726039.6,"total_display":"726,039.60","total_whole":"726,040","shares_owned_after":2877.0,"shares_owned_after_display":"2,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-09","filed_date":"2018-04-26","scope":"insider"},{"id":5967295,"accession":"0001214659-18-001007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-18-001007","line_url":"/filing/0001214659-18-001007#line-4","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":690000.0,"total_display":"690,000.00","total_whole":"690,000","shares_owned_after":2877.0,"shares_owned_after_display":"2,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-06","filed_date":"2018-02-08","scope":"insider"},{"id":6203576,"accession":"0001214659-18-000708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-18-000708","line_url":"/filing/0001214659-18-000708#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":26.1138,"price_display":"26.11","price_state":"stated","total_value":326422.5,"total_display":"326,422.50","total_whole":"326,423","shares_owned_after":2877.0,"shares_owned_after_display":"2,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-26","filed_date":"2018-01-29","scope":"insider"},{"id":6636009,"accession":"0001214659-18-000506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-18-000506","line_url":"/filing/0001214659-18-000506#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10814.0,"shares_display":"10,814","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":291978.0,"total_display":"291,978.00","total_whole":"291,978","shares_owned_after":2877.0,"shares_owned_after_display":"2,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":6268083,"accession":"0001214659-18-000368","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-18-000368","line_url":"/filing/0001214659-18-000368","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14725.0,"shares_display":"14,725","price_per_share":22.98649235993209,"price_display":"22.99","price_state":"stated","total_value":338476.1,"total_display":"338,476.10","total_whole":"338,476","shares_owned_after":2877.0,"shares_owned_after_display":"2,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-11","filed_date":"2018-01-11","scope":"insider","n_lines":2},{"id":4632480,"accession":"0001214659-17-006811","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-17-006811","line_url":"/filing/0001214659-17-006811#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10275.0,"shares_display":"10,275","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":184950.0,"total_display":"184,950.00","total_whole":"184,950","shares_owned_after":2395.0,"shares_owned_after_display":"2,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-16","filed_date":"2017-11-17","scope":"insider"},{"id":4716071,"accession":"0001214659-17-006386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-17-006386","line_url":"/filing/0001214659-17-006386#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7499.0,"shares_display":"7,499","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":104986.0,"total_display":"104,986.00","total_whole":"104,986","shares_owned_after":2670.0,"shares_owned_after_display":"2,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-03","scope":"insider"},{"id":4998806,"accession":"0001214659-17-005987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-17-005987","line_url":"/filing/0001214659-17-005987#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":56000.0,"total_display":"56,000.00","total_whole":"56,000","shares_owned_after":2670.0,"shares_owned_after_display":"2,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-04","filed_date":"2017-10-06","scope":"insider"},{"id":4858316,"accession":"0001190725-17-000150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001190725-17-000150","line_url":"/filing/0001190725-17-000150#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":770.0,"shares_display":"770","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":9240.0,"total_display":"9,240.00","total_whole":"9,240","shares_owned_after":2670.0,"shares_owned_after_display":"2,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-15","filed_date":"2017-09-18","scope":"insider"},{"id":8793327,"accession":"0001209191-15-047187","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-047187","line_url":"/filing/0001209191-15-047187","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":28.067747368421053,"price_display":"28.07","price_state":"stated","total_value":133321.8,"total_display":"133,321.80","total_whole":"133,322","shares_owned_after":1250.0,"shares_owned_after_display":"1,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-26","filed_date":"2015-05-27","scope":"insider","n_lines":2},{"id":8574513,"accession":"0001209191-15-023360","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-023360","line_url":"/filing/0001209191-15-023360","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":25.413333333333334,"price_display":"25.41","price_state":"stated","total_value":152480.0,"total_display":"152,480.00","total_whole":"152,480","shares_owned_after":3250.0,"shares_owned_after_display":"3,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-06","scope":"insider","n_lines":2},{"id":8080620,"accession":"0001209191-15-016079","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-016079","line_url":"/filing/0001209191-15-016079#line-5","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":23.0245,"price_display":"23.02","price_state":"stated","total_value":71375.95,"total_display":"71,375.95","total_whole":"71,376","shares_owned_after":1250.0,"shares_owned_after_display":"1,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-19","filed_date":"2015-02-19","scope":"insider"},{"id":8080613,"accession":"0001209191-15-016079","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-016079","line_url":"/filing/0001209191-15-016079","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":"0001599324","owner_name":"Christensen Jamie","owner_display_name":"Christensen Jamie","owner_url":"/insider/0001599324","role":"Officer (SVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1650.0,"shares_display":"1,650","price_per_share":22.486363636363638,"price_display":"22.49","price_state":"stated","total_value":37102.5,"total_display":"37,102.50","total_whole":"37,103","shares_owned_after":1250.0,"shares_owned_after_display":"1,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":43,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":43,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":43},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Officer (EVP & Chief Scientific Officer)","n_filings":29,"first_seen":"2015-02-19","last_seen":"2024-01-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001599324","retrieved_at":"2026-08-22T14:48:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}